Learning objectives

After watching this webinar, participants will be able to:

identify clinical and laboratory variables associated with a high risk of death and/or the need for mechanical ventilation;
understand that cardiomyocyte injury and (sub)clinical heart failure are the most frequent cardiac complications in COVID-19;
appreciate that high sensitivity cardiac troponin and natriuretic peptides are strongly associated with death and/or need for ICU admission and may help clinicians; and
know that novel biomarkers g. GDF-15) also may have value, but need further study.